MYRICX PHARMA LIMITED

Overview

Company Name	MYRICX PHARMA LIMITED
Company Status	Active
Legal Form	Private limited company
Company Number	12082645
Jurisdiction	England/Wales
Date of Creation	Jul 03, 2019

Summary

Has Super Secure PSCs	No
Has Charges	No
Has Insolvency History	No
Registered Office is in Dispute	No

What is the purpose of MYRICX PHARMA LIMITED?

Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

Where is MYRICX PHARMA LIMITED located?

Registered Office Address	125 Wood Street EC2V 7AW London United Kingdom
Undeliverable Registered Office Address	No

What are the latest accounts for MYRICX PHARMA LIMITED?

Next Accounts
Overdue	No
Next Accounts Period End On	Jul 31, 2025
Next Accounts Due On	Apr 30, 2026
Last Accounts
Last Accounts Made Up To	Jul 31, 2024

What is the status of the latest confirmation statement for MYRICX PHARMA LIMITED?

Last Confirmation Statement
Last Confirmation Statement Made Up To	Jul 02, 2025
Next Confirmation Statement Due	Jul 16, 2025
Next Confirmation Statement Made Up To	Jul 02, 2024
Overdue	No

What are the latest filings for MYRICX PHARMA LIMITED?

Filings

Date

Description

Document

Type

Feb 13, 2025

Termination of appointment of Grant Hawthorne as a secretary on Nov 30, 2024

1 pages

TM02

Feb 13, 2025

Appointment of Pennsec Limited as a secretary on Feb 11, 2025

2 pages

AP04

Feb 13, 2025

Termination of appointment of Paolo Paoletti as a director on Jan 27, 2025

1 pages

TM01

Dec 20, 2024

Statement of capital following an allotment of shares on Dec 19, 2024

Capital: GBP 336.7567

4 pages

SH01

Dec 09, 2024

Accounts for a small company made up to Jul 31, 2024

11 pages

Oct 25, 2024

Statement of capital following an allotment of shares on Oct 24, 2024

Capital: GBP 336.27177

4 pages

SH01

Oct 02, 2024

Appointment of Dr Paolo Paoletti as a director on Sep 20, 2024

2 pages

AP01

Sep 03, 2024

Second filing of Confirmation Statement dated Jul 02, 2024

7 pages

RP04CS01

Annotations
Date	Annotation
Sep 06, 2024	Clarification A second filed CS01 (Capital and Shareholders) was filed on 20/08/24

Aug 30, 2024

Statement of capital following an allotment of shares on Aug 19, 2024

Capital: GBP 335.81925

4 pages

SH01

Jul 15, 2024

Statement of capital following an allotment of shares on Jun 28, 2024

Capital: GBP 335.81925

4 pages

SH01

Jul 12, 2024

Statement of capital following an allotment of shares on Jun 28, 2024

Capital: GBP 330.68138

4 pages

SH01

Jul 09, 2024

Resolutions

Resolutions

2 pages

RESOLUTIONS

Resolutions
Category	Description	Type
capital	Resolution of removal of pre-emption rights	RES11
incorporation	Resolution of adoption of Articles of Association	RES01
capital	Resolution of allotment of securities	RES10

Jul 09, 2024

Memorandum and Articles of Association

57 pages

Jul 08, 2024

Confirmation statement made on Jul 02, 2024 with updates

5 pages

CS01

Jul 08, 2024

Appointment of Michael Karl Bauer as a director on Jun 28, 2024

2 pages

AP01

Jul 05, 2024

Appointment of Dr Lucille Conroy as a director on Jun 28, 2024

2 pages

AP01

Jul 05, 2024

Termination of appointment of Edward William Tate as a director on Jun 28, 2024

1 pages

TM01

Jun 20, 2024

Termination of appointment of Rachael Brake as a director on Jun 19, 2024

1 pages

TM01

May 20, 2024

Resolutions

Resolutions

1 pages

RESOLUTIONS

Resolutions
Category	Date	Description	Type
capital		Resolution of allotment of securities	RES10

Mar 14, 2024

Statement of capital following an allotment of shares on Mar 14, 2024

Capital: GBP 170.68141

3 pages

SH01

Mar 04, 2024

Resolutions

Resolutions

1 pages

RESOLUTIONS

Resolutions
Category	Date	Description	Type
capital		Resolution of allotment of securities	RES10

Feb 13, 2024

Statement of capital following an allotment of shares on Feb 08, 2024

Capital: GBP 168.21577

3 pages

SH01

Feb 07, 2024

Total exemption full accounts made up to Jul 31, 2023

12 pages

Nov 17, 2023

Termination of appointment of Roberto Celeste Ercole Solari as a director on Nov 10, 2023

1 pages

TM01

Nov 17, 2023

Appointment of Christopher John Martin as a director on Nov 10, 2023

2 pages

AP01

View All Filings

Who are the officers of MYRICX PHARMA LIMITED?

Officers

Name

Appointed On

Resigned On

Role

Address

Company Identification

Country of Residence

Nationality

Date of Birth

Occupation

Number

PENNSEC LIMITED

Feb 11, 2025

Secretary

Wood Street

EC2V 7AW London

125

United Kingdom

Identification Type	UK Limited Company
Registration Number	1751339

50775150007

BAUER, Michael Karl

Jun 28, 2024

Director

2900 Hellerup

Tuborg Havnevej 19

Denmark

German

1963-10

Partner

324863800001

BHAMAN, Maina

Oct 29, 2019

Director

Boulevard Haussmann

75009 Paris

France

United Kingdom

British

1972-2

Venture Capitalist

198315040001

CARR, Robin Arthur Ellis, Dr

Oct 11, 2022

Director

Wood Street

EC2V 7AW London

125

United Kingdom

British

1960-10

Ceo

301257910001

CONROY, Lucille, Dr

Jun 28, 2024

Director

Jermyn Street

SW1Y 6DN London

United Kingdom

British

1990-1

Director

324834330001

MARTIN, Christopher John, Dr

Nov 10, 2023

Director

Wood Street

EC2V 7AW London

125

United Kingdom

Switzerland

British

1958-7

Engineer

37607120004

TOBIN, Jonathan Leslie

Apr 19, 2023

Director

Wood Street

EC2V 7AW London

125

United Kingdom

British

1982-12

Venture Capitalist

266670610001

HAWTHORNE, Grant

Dec 20, 2019

Nov 30, 2024

Secretary

Gunnels Wood Road

SG1 2FX Stevenage

Stevenage Bioscience Catalyst

Hertfordshire

United Kingdom

265539770002

BRAKE, Rachael

Feb 23, 2021

Jun 19, 2024

Director

Wood Street

EC2V 7AW London

125

United Kingdom

United States

Australian,American

1971-7

Scientist

282839700001

PAOLETTI, Paolo, Dr

Sep 20, 2024

Jan 27, 2025

Director

Wood Street

EC2V 7AW London

125

United Kingdom

Italy

Italian,American

1950-10

Md, Consultant, Advisor, Board Member

327782270001

SOLARI, Roberto Celeste Ercole, Dr

Jul 03, 2019

Nov 10, 2023

Director

Wood Street

EC2V 7AW London

125

United Kingdom

British,Italian

1956-11

Company Director

64425460001

TATE, Edward William, Professor

Jul 03, 2019

Jun 28, 2024

Director

Wood Street

EC2V 7AW London

125

United Kingdom

British

1975-10

Company Director

260105850001

THOMPSON, Henry Stephen Grammer, Dr

Oct 29, 2019

Apr 19, 2023

Director

Wood Street

EC2V 7AW London

125

United Kingdom

Australia

British,Australian

1961-10

Director

264161940001

View Detailed Information on Officers and People with Significant Control

Who are the persons with significant control of MYRICX PHARMA LIMITED?

Persons with significant controls
Name	Notified On	Address	Ceased
Professor Edward William Tate Gunnels Wood Road SG1 2FX Stevenage Stevenage Bioscience Catalyst Hertfordshire United Kingdom	Jul 03, 2019	Gunnels Wood Road SG1 2FX Stevenage Stevenage Bioscience Catalyst Hertfordshire United Kingdom	Yes
	Nationality: British Country of Residence: United Kingdom
	Natures of Control The person holds, directly or indirectly, more than 50% but not more than 75% of the shares in the company. The person holds, directly or indirectly, more than 50% but not more than 75% of the voting rights in the company. The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

View Detailed Information on Persons with Significant Control

What are the latest statements on persons with significant control for MYRICX PHARMA LIMITED?

Persons with signficant control statements
Notified On	Ceased On	Statement
Aug 06, 2020		The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company

View Detailed Information on Persons with Significant Control Statements

Data Source

UK Companies House
The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
license: CC0